Supporting Organizations and Publications
Intellectual Property Watch, based in Geneva, Switzerland, provides independent news and information on international intellectual property policy and law. With a global network of professional journalists, IP-Watch publishes articles, expert opinions, and other features continuously on our website, www.ip-watch.org, with notification via e-mail alert, RSS, Twitter and Facebook.
IPPro The Internet is intellectual property's only fortnightly newsletter. It is the key resource for professionals who enforce, protect and promote intellectual property online, covering the entire spectrum of intellectual property as it relates to the internet, from trademark infringement cases to the increasingly complex domain name space. It will report the news as it happens and it will provide analysis from industry experts who are on the inside and outside of key industry developments.
IPPro The Internet focuses on:
Online patent, trademark and copyright infringement
Trademark and patent filings
Technology licensing
Online counterfeiting
Domain name developments and disputes
Social media developments and disputes
Brand promotion through online advertising and social media
Regulatory developments
IP office developments
IP technology
The Patent Lawyer Magazine is a special focus international legal publication that focuses solely on the patent industry, patent lawyers and patent law firms. The magazine is packed full of information, special features, interviews, case comments, special country focus, patent litigation roundup, service provider focus, patent people moves, company press releases, recruitment, inventor section and a dedicated patent directory of services.
The Patent Lawyer Magazine is the only magazine to exclusively focus on patent law, patent lawyers, inventors and those specialist companies that provide patent related services. The Patent Lawyer Magazine will be sent via hardcopy and online to over 10,000 recipients including in-house Patent Lawyers, Private Practice Patent Lawyers, and C Suite Executives within large pharmaceutical and technology companies around the world.